Here, we provide evidence linking higher PTH levels at diagnosis or within the subsequent 5-year period to inferior EFS, but unchanged OS, in childhood embryonal and lymphatic malignancies, as well as in childhood malignant primary brain tumors. This evidence concerns the gene PTH and primary brain neoplasm.